Product category:
Laboratory and scientific databases
News Release from: Inforsense
Edited by the Laboratorytalk Editorial
Team on 24 April 2002
InforSense appoints president and COO
Paul Davie, ex-European general manager and senior director consultancy services for Accelrys, takes key position at software firm
InforSense, a provider of discovery informatics platforms, has appointed Paul Davie to the position of president and chief operating officer Before joining InforSense, Davie was European general manager and senior director consultancy services for Accelrys
This article was originally published on Laboratorytalk on 3 May 2002 at 8.00am (UK)
Related stories
Industrial scale discovery management
Upgraded softwatre package addresses needs of life sciences and research organisations requiring a unified platform for data integration, data analysis and discovery process design
Informatics system wins prestigious award
Researchers demonstrated their innovative ability to analyse large-scale genomic data in real time using intercontinental distributed computing resources
He will be responsible for InforSense's overall business operations, focusing particularly on marketing, sales, and service.
"InforSense's success lies in large part on our investment in people," said Yike Guo, CEO of InforSense.
"Paul brings extensive international commercial experience in the life science industry, gained in both large companies and entrepreneurial ventures.
This, combined with his leadership skills, makes him a fitting President and COO to lead InforSense's expansion in providing world-class discovery software to the life science market." Davie has 18 years commercial experience in discovery informatics in a wide range of senior roles.
He spent eight years at Chemical Design before going on to join Oxford Molecular in 1992, where he became European sales director.
He was responsible for sales, customer support and consultancy services and was part of the management team that successfully took the company through an IPO in 1994.
Following OML's acquisition by Pharmacopeia, he was made European general manager of its merged software division, Accelrys.
He is a chemistry graduate from Oxford University and an MBA from the Open University Business School.
• Inforsense: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
